Newsletter
The Race to Prepare for Medicare’s New Drug Pricing Powers

Tradeoffs

The Race to Prepare for Medicare’s New Drug Pricing Powers

December 22, 2022

The Race to Prepare for Medicare’s New Drug Pricing Powers

The Inflation Reduction Act gives Medicare historic new powers to control prescription drug prices. We go inside the government’s race to implement these new powers — and the pharmaceutical industry’s efforts to blunt their impact.

Guests:

Alice Valder Curran, JD, Partner, Hogan Lovells

Sean Dickson, JD, MPH, Director of Health Policy, West Health Policy Center

Amber Jessup, PhD, Chief Economist, Office of Inspector General, Department of Health and Human Services

Mark Newsom, Founder and Principal, Health Evaluations

Learn more and read a full transcript on our website.

Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.

Support this type of journalism today, with a gift.

Follow us on Twitter


Hosted on Acast. See acast.com/privacy for more information.

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
A Diverse Skill Set Peter McCanna is chief executive officer (CEO) at Baylor Scott & White Health, the largest not- for-profit health system in Texas. Through 51 hospitals and more than 1,200 access points, including flagship academic medical centers in Dallas, Fort Worth and Temple, the system offers the full continuum of care, from primary to award-winning specialty care, as well as an array of virtual and in-home services.